Shay Capital LLC Bausch Health Companies Inc. Transaction History

Shay Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$6.28 - $9.85 $157,000 - $246,250	-25,000 Reduced 35.71%	45,000 $364,000
Q4 2022 Feb 14, 2023	BUY	$6.09 - $7.93 $152,250 - $198,250	25,000 Added 55.56%	70,000 $439,000
Q3 2022 Nov 14, 2022	SELL	$4.58 - $9.21 $68,700 - $138,150	-15,000 Reduced 25.0%	45,000 $310,000
Q2 2022 Aug 15, 2022	BUY	$7.06 - $23.63 $35,300 - $118,150	5,000 Added 9.09%	60,000 $502,000
Q1 2022 May 16, 2022	BUY	$21.6 - $27.79 $162,000 - $208,425	7,500 Added 15.79%	55,000 $1.26 Million
Q4 2021 Feb 14, 2022	BUY	$23.0 - $29.01 $1.09 Million - $1.38 Million	47,500 New	47,500 $1.31 Million

255

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $3.07B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Shay Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Shay Capital LLC with notifications on news.